Literature DB >> 3079784

Interferon-gamma induces class I HLA and beta 2-microglobulin expression by human amnion cells.

J S Hunt, G W Wood.   

Abstract

In contrast to other human nucleated cells, amnionic epithelial cells do not normally express class I HLA antigens. It is not known whether the failure of display of those antigens occurs because genes for HLA expression are deleted or are defective, or if gene expression is repressed. The results of the present study demonstrate that amnionic epithelial cells exposed to IFN-gamma express levels of class I HLA antigens and beta 2-microglobulin that are readily detectable in immunoperoxidase and immunofluorescence stains. The findings suggest that failure of transcription may be responsible for failure of normal expression of class I HLA antigens and beta 2-microglobulin by cells of the amnion membrane. Class II antigens, which are normally expressed by very few cell types, were not expressed by amnion cells under any test conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Fetal allograft survival in immunocompetent recipients is age dependent and organ specific.

Authors:  R P Foglia; J DiPreta; M B Statter; P K Donahoe
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

2.  Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein.

Authors:  M A Blanar; E C Boettger; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Isolation and partial characterization of human amniotic epithelial cells: the effect of trypsin.

Authors:  Meraj Tabatabaei; Nariman Mosaffa; Shohreh Nikoo; Mahmood Bozorgmehr; Roya Ghods; Somaieh Kazemnejad; Simin Rezania; Bahareh Keshavarzi; Soheila Arefi; Fahimeh Ramezani-Tehrani; Ebrahim Mirzadegan; Amir-Hassan Zarnani
Journal:  Avicenna J Med Biotechnol       Date:  2014-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.